Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy
- PMID: 2829837
- PMCID: PMC1148605
- DOI: 10.1042/bj2480697
Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy
Abstract
The size of the mutant N-acetylglucosamine 1-phosphotransferase in Golgi membranes from fibroblasts of patients with I-cell disease and classical pseudo-Hurler polydystrophy, which comprised one complementation group characterized by deficiency towards both artificial and natural acceptor substrates, was significantly smaller than the normal enzyme, 151-174 kDa compared with 225-278 kDa. The size of the mutant enzyme from cell lines of patients with variant forms of pseudo-Hurler polydystrophy, which comprised another complementation group characterized by normal activity towards mono- and oligo-saccharide substrates, was significantly larger than the normal enzyme, ranging from 321 to 356 kDa in two families and from 528 to 547 kDa in a third family. These findings suggest that the mutations in I-cell disease and classical pseudo-Hurler polydystrophy result in a missing enzyme component, which renders the enzyme catalytically inefficient toward any type of acceptor substrate. In contrast, the mutations in the variant forms of pseudo-Hurler polydystrophy produce a larger enzyme molecule which is active toward small substrates but is incapable of binding natural lysosomal glycoprotein substrates.
Similar articles
-
Characterization of the mutant N-acetylglucosaminylphosphotransferase in I-cell disease and pseudo-Hurler polydystrophy: complementation analysis and kinetic studies.Enzyme. 1986;35(2):106-16. doi: 10.1159/000469330. Enzyme. 1986. PMID: 3017692
-
Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.J Clin Invest. 1981 May;67(5):1574-9. doi: 10.1172/jci110189. J Clin Invest. 1981. PMID: 6262380 Free PMC article.
-
Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes.Proc Natl Acad Sci U S A. 1981 Dec;78(12):7773-7. doi: 10.1073/pnas.78.12.7773. Proc Natl Acad Sci U S A. 1981. PMID: 6461005 Free PMC article.
-
[I-cell disease and pseudo-Hurler polydystrophy].Nihon Rinsho. 1995 Dec;53(12):3028-34. Nihon Rinsho. 1995. PMID: 8577054 Review. Japanese.
-
[I-cell disease: elucidation of the enzyme defect and its molecular biology significance].Verh K Acad Geneeskd Belg. 1989;51(3):231-67. Verh K Acad Geneeskd Belg. 1989. PMID: 2686262 Review. Dutch.
Cited by
-
Cell cycle-dependent phosphorylation of Sec4p controls membrane deposition during cytokinesis.J Cell Biol. 2016 Sep 12;214(6):691-703. doi: 10.1083/jcb.201602038. J Cell Biol. 2016. PMID: 27621363 Free PMC article.
-
Cell biology of membrane trafficking in human disease.Int Rev Cytol. 2006;252:1-69. doi: 10.1016/S0074-7696(06)52005-4. Int Rev Cytol. 2006. PMID: 16984815 Free PMC article. Review.
-
Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.Am J Hum Genet. 1992 Jan;50(1):137-44. Am J Hum Genet. 1992. PMID: 1309624 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources